Delivery Order SPE2DB22D3016-SPE2DB24FBBT9

Award Date 7/22/24
Potential Completion Date 8/12/24
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Opdivo, a specialty cancer medication. The contract is a firm-fixed-price delivery order with a ceiling value of $9,937.86 and a period of performance through May 29, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $9,937.86 and is for the supply of 240 mg/24 ml vials of the cancer medication Opdivo. The contract is not set aside and is a firm fixed-price delivery order with a performance period through May 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Opdivo 240 mg/24 ml vials. The contract has a ceiling value of $14,906.79 and a period of performance ending on June 18, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,937.86, is for the supply of Opdivo, a specialty medication used for cancer treatment. The contract has an ultimate completion date of April 15, 2025 and is a firm fixed-price agreement. This award is associated with a larger Indefinite Delivery Contract (IDC) held...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of 240 mg/24 mL vials of the prescription drug Opdivo. The delivery order has a firm fixed price of $7,647.40 and a period of performance through October 31, 2024. AmerisourceBergen, a major pharmaceutical distributor, has an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999 through December 2025 for providing a comprehensive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Opdivo, a 240 mg/24 ml vial medication, with a ceiling value of $40,418.81 and a performance period that runs through June 4, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of OPDIVO 100 MG/10 ML VIAL 10ML. The firm fixed-price contract has a ceiling value of $9,974.55 and runs through December 12, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as the primary vehicle for providing a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Opdivo 240 mg/24 ml vials, a specialty cancer medication. The contract has a ceiling value of $49,689.30 and is a firm fixed-price delivery order. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Opdivo 240 mg/24 ml vials, a prescription medication. The contract has a firm fixed price of $9,937.86 and a performance period ending on May 28, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $9,739.10, is for the delivery of Opdivo Qvantig 600 mg-10,000 5 ml, a medication used in the treatment of various medical conditions. The contract is a firm fixed-price delivery order and is not set aside for any special type of business. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB24FBBT9
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Opdivo, a specialty oncology medication. The contract has a ceiling value of $11,471.10 and runs through August 12, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 10/21/24, 9:41 AM